1![THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO The University of New Mexico THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO The University of New Mexico](https://www.pdfsearch.io/img/fe81bd12853afb0bc2fcb2f81ec97456.jpg) | Add to Reading ListSource URL: pharmacyce.unm.eduLanguage: English - Date: 2016-08-17 16:07:17
|
---|
2![. 4 THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY . 4 THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY](https://www.pdfsearch.io/img/3c3d3450dd711ac5a41c4535c80fe376.jpg) | Add to Reading ListSource URL: pharmacyce.unm.eduLanguage: English - Date: 2016-08-17 16:07:10
|
---|
3![By including immune cells in their model, Perelson and Conway determined that an In his work toward understanding the early diagnosis and prompt initiation of infection dynamics of HIV, the Laboratory’s treatment can l By including immune cells in their model, Perelson and Conway determined that an In his work toward understanding the early diagnosis and prompt initiation of infection dynamics of HIV, the Laboratory’s treatment can l](https://www.pdfsearch.io/img/16c96fe845634574afd011a69595b13b.jpg) | Add to Reading ListSource URL: www.lanl.govLanguage: English - Date: 2016-04-21 10:50:56
|
---|
4![Anti-PSMA Antibodies Novel Agents for Diagnosis and Therapy of Prostate Cancer Technology The Prostate Specific Membrane antigen (PSMA) is highly expressed by virtually all prostate cancers and is currently the focus of Anti-PSMA Antibodies Novel Agents for Diagnosis and Therapy of Prostate Cancer Technology The Prostate Specific Membrane antigen (PSMA) is highly expressed by virtually all prostate cancers and is currently the focus of](https://www.pdfsearch.io/img/1ad9c9fdcdbcdbfd002f99c9da083ee8.jpg) | Add to Reading ListSource URL: www.campus-technologies.deLanguage: English - Date: 2015-02-19 09:17:00
|
---|
5![Developments in patient dosimetry for unsealed sources Gerhard Glatting Medical Radiation Physics/Radiation Protection Medical Faculty Mannheim, University Heidelberg, Germany Developments in patient dosimetry for unsealed sources Gerhard Glatting Medical Radiation Physics/Radiation Protection Medical Faculty Mannheim, University Heidelberg, Germany](https://www.pdfsearch.io/img/32766d5fc957063d2ec7947c24a55e57.jpg) | Add to Reading ListSource URL: rpop.iaea.orgLanguage: English - Date: 2012-12-13 09:32:30
|
---|
6![Session 4 Radiation protection of patients, staff and the public during therapeutic use of sealed and unsealed radioactive sources Summary of Contributed Papers Makoto Hosono, MD PhD Session 4 Radiation protection of patients, staff and the public during therapeutic use of sealed and unsealed radioactive sources Summary of Contributed Papers Makoto Hosono, MD PhD](https://www.pdfsearch.io/img/7b4a6f8bb99aaadd4d938dabe7223094.jpg) | Add to Reading ListSource URL: rpop.iaea.orgLanguage: English - Date: 2012-12-13 09:32:30
|
---|
7![Radioimmunotherapy Dosimetry William D. Erwin, M.S. Department of Imaging Physics UT M. D. Anderson Cancer Center
Radioimmunotherapy Radioimmunotherapy Dosimetry William D. Erwin, M.S. Department of Imaging Physics UT M. D. Anderson Cancer Center
Radioimmunotherapy](https://www.pdfsearch.io/img/1b1537dadd05d93230ad44d60ae97211.jpg) | Add to Reading ListSource URL: www.aapm.orgLanguage: English - Date: 2005-10-18 14:16:03
|
---|
8![The recent approval of 90Y-labeled Zevalin (IDEC Pharmaceuticals Corp., San Diego, CA) for radioimmunotherapy of non-Hodgkin’s lymphoma has highlighted the regulatory requirement of patient-specific internal radiati The recent approval of 90Y-labeled Zevalin (IDEC Pharmaceuticals Corp., San Diego, CA) for radioimmunotherapy of non-Hodgkin’s lymphoma has highlighted the regulatory requirement of patient-specific internal radiati](https://www.pdfsearch.io/img/f163ca63e5c86e626d31bb0657a74838.jpg) | Add to Reading ListSource URL: www.aapm.orgLanguage: English - Date: 2005-10-18 14:16:03
|
---|
9![Scan for mobile link. Radioimmunotherapy What is Radioimmunotherapy and how is it used? Radioimmunotherapy (RIT) is a combination of radiation therapy and immunotherapy. In immunotherapy, a laboratory-produced molecule Scan for mobile link. Radioimmunotherapy What is Radioimmunotherapy and how is it used? Radioimmunotherapy (RIT) is a combination of radiation therapy and immunotherapy. In immunotherapy, a laboratory-produced molecule](https://www.pdfsearch.io/img/85f5d9034dd1a87e8bca9b722568d981.jpg) | Add to Reading ListSource URL: www.radiologyinfo.orgLanguage: English - Date: 2014-10-06 16:53:40
|
---|
10![Label - Indiclor, High Purity Indium chloride In-111 Sterile Solution Label - Indiclor, High Purity Indium chloride In-111 Sterile Solution](https://www.pdfsearch.io/img/ef678196793201b12baf4a9147fa78ae.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|